Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.8503
-0.0497 (-5.52%)
At close: Aug 1, 2025, 4:00 PM
0.8500
-0.0003 (-0.04%)
After-hours: Aug 1, 2025, 6:45 PM EDT

SpringWorks Therapeutics Analyst Ratings

Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$4.00
Upside
+370.42%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$5$4
Strong BuyMaintains$5$4+370.42%Jul 29, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$7$5
Strong BuyMaintains$7$5+488.03%Jul 1, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$10$7
Strong BuyMaintains$10$7+723.24%Jan 24, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong BuyReiterates$10+1,076.06%Dec 2, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong BuyReiterates$10+1,076.06%Nov 25, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong BuyReiterates$10+1,076.06%Jul 18, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$10
Strong BuyInitiates$10+1,076.06%Jul 10, 2024
Maxim Group
Maxim Group
Strong Buy
Maintains
$3$12
Strong BuyMaintains$3$12+1,311.27%Mar 5, 2024
Maxim Group
Maxim Group
Strong Buy
Initiates
$2
Strong BuyInitiates$2+135.21%Jul 21, 2023